Form 4 for RGEN REPLIGEN CORP
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0000950170-24-073829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-14 | RGEN | DAWES KAREN A | Dir | M - OptEx | $67.71 | +2,953 | 88.2K | +3% | +$199.9K |
| D | 2024-06-14 | 2024-06-14 | RGEN | DAWES KAREN A | Dir | M - OptEx | $0.00 | +2,953 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | M | A | 2,953 | $67.71 | 88,170 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-14 | M | A | 2,953 | $0.00 | 0 | D | $67.71 · — to 2029-05-15 | 2,953 Common Stock | (F1) This option is fully vested and exercisable. |